Page 132 - 《中国药房》2022年14期

critically patients with and without kidney dysfunction[J]. sion in critically ill patients[J]. Antimicrob Agents Che-
BMC Anesthesiol，2015，15：95. mother，2017，61（9）：e00654-e00617.
[20] BARBOT A，VENISSE N，RAYEH F，et al. Pharmacoki- [32] ROBERTS J A，UDY A A，JARRETT P，et al. Plasma and
netics and pharmacodynamics of sequential intravenous target-site subcutaneous tissue population pharmacokine-
and subcutaneous teicoplanin in critically ill patients tics and dosing simulations of cefazolin in post-trauma
without vasopressors[J]. Intensive Care Med，2003，29 critically ill patients[J]. J Antimicrob Chemother，2015，70
（9）：1528-1534. （5）：1495-1502.
[21] 唐莲，石璐，薛宏志，等.肾功能亢进对替考拉宁高剂量治 [33] JOYNT G M，LIPMAN J，GOMERSALL C D，et al. The
疗方案下患者血药谷浓度的影响[J].中国药房，2020，31 pharmacokinetics of once-daily dosing of ceftriaxone in
（21）：2650-2655. critically ill patients[J]. J Antimicrob Chemother，2001，47
[22] GOBOOVA M，KUZELOVA M，Fazekas T，et al. The im- （4）：421-429.
pact of therapeutic drug monitoring（TDM）in optimizing [34] LIPMAN J，WALLIS S C，BOOTS R J. Cefepime versus
dosage regimens of gentamicin in patients with augmen- cefpirome：the importance of creatinine clearance[J].
ted renal clearance[J]. Int J Clin Pharm，2016，38（2）：596. Anesth Analg，2003，97（4）：1149-1154.
[23] NICOLAU D P，FREEMAN C D，BELLIVEAU P P，et al. [35] LIPMAN J，WALLIS S C，RICKARD C M，et al. Low
Experience with a once-daily aminoglycoside program cefpirome levels during twice daily dosing in critically ill
administered to 2，184 adult patients[J]. Antimicrob septic patients：pharmacokinetic modelling calls for more
Agents Chemother，1995，39（3）：650-655. frequent dosing[J]. Intensive Care Med，2001，27（2）：
[24] FALCONE M，RUSSO A，VENDITTI M，et al. Conside- 363-370.
rations for higher doses of daptomycin in critically ill [36] CONIL J M，GEORGES B，LAVIT M，et al. Pharmacoki-
patients with methicillin-resistant Staphylococcus aureus netics of ceftazidime and cefepime in burn patients：the
bacteremia[J]. Clin Infect Dis，2013，57（11）：1568-1576. importance of age and creatinine clearance[J]. Int J Clin
[25] UDY A A，ROBERTS J A，BOOTS R J，et al. Augmented Pharmacol Ther，2007，45（10）：529-538.
renal clearance：implications for antibacterial dosing in [37] NOVELLI A，ADEMBRI C，LIVI P，et al. Pharmacokinetic
the critically ill[J]. Clin Pharmacokinet，2010，49（1）：1- evaluation of meropenem and imipenem in critically ill
16. patients with sepsis[J]. Clin Pharmacokinet，2005，44（5）：
[26] SIME F B，UDY A A，ROBERTS J A. Augmented renal 539-549.
clearance in critically ill patients：etiology，definition and [38] TRÖGER U，DRUST A，MARTENS-LOBENHOFFER J，
implications for beta-lactam dose optimization[J]. Curr et al. Decreased meropenem levels in Intensive Care Unit
Opin Pharmacol，2015，24：1-6. patients with augmented renal clearance：benefit of thera-
[27] HUTTNER A，VON DACH E，RENZONI A，et al. Aug- peutic drug monitoring[J]. Int J Antimicrob Agents，2012，
mented renal clearance，low β-lactam concentrations and 40（4）：370-372.
clinical outcomes in the critically ill：an observational pro- [39] LAMOTH F，BUCLIN T，CSAJKA C，et al. Reassess-
spective cohort study[J]. Int J Antimicrob Agents，2015，45 ment of recommended imipenem doses in febrile neutrope-
（4）：385-392. nic patients with hematological malignancies[J]. Antimi-
[28] FELTON T W，HOPE W W，LOMAESTRO B M，et al. crob Agents Chemother，2009，53（2）：785-787.
Population pharmacokinetics of extended-infusion pipe- [40] ROBERTS J A，LIPMAN J. Optimal doripenem dosing
racillin-tazobactam in hospitalized patients with nosoco- simulations in critically ill nosocomial pneumonia patients
mial infections[J]. Antimicrob Agents Chemother，2012， with obesity，augmented renal clearance，and decreased
56（8）：4087-4094. bacterial susceptibility[J]. Crit Care Med，2013，41（2）：
[29] DE WAELE J J，CARRETTE S，CARLIER M，et al. The- 489-495.
rapeutic drug monitoring-based dose optimisation of pipe- [41] ROBERTS J A，COTTA M O，COJUTTI P，et al. Does
racillin and meropenem：a randomised controlled trial[J]. critical illness change levofloxacin pharmacokinetics? [J].
Intensive Care Med，2014，40（3）：380-387. Antimicrob Agents Chemother，2015，60（3）：1459-1463.
[30] AKERS K S，NIECE K L，CHUNG K K，et al. Modified [42] KHACHMAN D，CONIL J M，GEORGES B，et al. Opti-
Augmented Renal Clearance score predicts rapid piperacil- mizing ciprofloxacin dosing in intensive care unit patients
lin and tazobactam clearance in critically ill surgery and through the use of population pharmacokinetic-pharmaco-
trauma patients[J]. J Trauma Acute Care Surg，2014，77（3 dynamic analysis and Monte Carlo simulations[J]. J Anti-
Suppl 2）：S163-S170. microb Chemother，2011，66（8）：1798-1809.
[31] QUINTON M C，BODEAU S，KONTAR L，et al. Neuro- （收稿日期：2022-02-08 修回日期：2022-06-06）
toxic concentration of piperacillin during continuous infu- （编辑：邹丽娟）

·1786 · China Pharmacy 2022 Vol. 33 No. 14 中国药房 2022年第33卷第14期